Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-461 in Advanced Prostate Cancer
NCT00036075Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of CP-461 in Prostate Adenocarcinoma (PRAD), sponsored by Astellas Pharma. Started Aug 2001; status: completed.
02
Drugs
CP-461
03
Conditions
Prostate Adenocarcinoma (PRAD)
Beyond the preview
Go deeper on NCT00036075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036075.